TY - JOUR
T1 - Synergistic effects on gene delivery - Co-formulation of small disulfide-linked dendritic polycations with Lipofectamine 2000™
AU - Hardy, John G.
AU - Love, Christine S.
AU - Gabrielson, Nathan P.
AU - Pack, Daniel W.
AU - Smith, David K.
PY - 2009
Y1 - 2009
N2 - This paper describes the application of gene delivery vectors based on connecting together two well-defined low-generation poly(l-lysine) (PLL) dendrons using a disulfide-containing linker unit. We report that the transfection ability of these vectors in their own right is relatively low, because the low-generation number limits the endosomal buffering capacity. Importantly, however, we demonstrate that when applied in combination with Lipofectamine 2000™, a vector from the cationic lipid family, these small cationic additives significantly enhance the levels of gene delivery (up to four-fold). Notably, the cationic additives have no effect on the levels of transfection observed with a cationic polymer, such as DEAE dextran. We therefore argue that the synergistic effects observed with Lipofectamine 2000™ arise as a result of combining the delivery advantages of two different classes of vector within a single formulation, with our dendritic additives providing a degree of pH buffering within the endosome. As such, the data we present indicate that small dendritic structures, although previously largely overlooked for gene delivery owing to their inability to transfect in their own right, may actually be useful well-defined additives to well-established vector systems in order to enhance the gene delivery payload.
AB - This paper describes the application of gene delivery vectors based on connecting together two well-defined low-generation poly(l-lysine) (PLL) dendrons using a disulfide-containing linker unit. We report that the transfection ability of these vectors in their own right is relatively low, because the low-generation number limits the endosomal buffering capacity. Importantly, however, we demonstrate that when applied in combination with Lipofectamine 2000™, a vector from the cationic lipid family, these small cationic additives significantly enhance the levels of gene delivery (up to four-fold). Notably, the cationic additives have no effect on the levels of transfection observed with a cationic polymer, such as DEAE dextran. We therefore argue that the synergistic effects observed with Lipofectamine 2000™ arise as a result of combining the delivery advantages of two different classes of vector within a single formulation, with our dendritic additives providing a degree of pH buffering within the endosome. As such, the data we present indicate that small dendritic structures, although previously largely overlooked for gene delivery owing to their inability to transfect in their own right, may actually be useful well-defined additives to well-established vector systems in order to enhance the gene delivery payload.
UR - http://www.scopus.com/inward/record.url?scp=59849091544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=59849091544&partnerID=8YFLogxK
U2 - 10.1039/b818469k
DO - 10.1039/b818469k
M3 - Article
C2 - 19194595
AN - SCOPUS:59849091544
SN - 1477-0520
VL - 7
SP - 789
EP - 793
JO - Organic and Biomolecular Chemistry
JF - Organic and Biomolecular Chemistry
IS - 4
ER -